Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
- July - August - September -
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
- 2013 -
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
September 2013 - 27 products
IP
CI
Bicalutamid Sandoz eco 50 mg
30 Tablet(s)
75.98
99.05
10 %
Coated tablets: Bicalutamidum 50 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Bicalutamid Sandoz eco 50 mg
100 Tablet(s)
160.00
190.40
10 %
Coated tablets: Bicalutamidum 50 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Bicalutamid Sandoz eco 150 mg
30 Tablet(s)
138.16
166.65
10 %
Coated tablets: Bicalutamidum 150 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Bicalutamid Sandoz eco 150 mg
100 Tablet(s)
292.13
334.10
10 %
Coated tablets: Bicalutamidum 150 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Moxifloxacin-Mepha
5 Tablet(s)
15.54
33.30
10 %
Coated tablets: Moxifloxacinum 400 mg
Mepha Pharma AG
●
A / SL / SG
FB
G
IP
CI
Moxifloxacin-Mepha
7 Tablet(s)
21.62
39.95
10 %
Coated tablets: Moxifloxacinum 400 mg
Mepha Pharma AG
●
A / SL / SG
FB
G
IP
CI
Moxifloxacin-Mepha
10 Tablet(s)
27.38
46.20
10 %
Coated tablets: Moxifloxacinum 400 mg
Mepha Pharma AG
●
A / SL / SG
FB
G
IP
CI
Bisoprolol Zentiva 2.5 mg
30
2.75
12.20
10 %
Tablette: Bisoprololi Fumaras 2.5 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Bisoprolol Zentiva 2.5 mg
100
7.04
16.90
10 %
Tablette: Bisoprololi Fumaras 2.5 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Bisoprolol Zentiva 5 mg
30
4.37
14.00
10 %
Tablette: Bisoprololi Fumaras 5 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Bisoprolol Zentiva 5 mg
100
12.05
29.50
10 %
Tablette: Bisoprololi Fumaras 5 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Bisoprolol Zentiva 10 mg
30
7.82
17.75
10 %
Tablette: Bisoprololi Fumaras 10 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Bisoprolol Zentiva 10 mg
100
22.15
40.50
10 %
Tablette: Bisoprololi Fumaras 10 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
V/S
Intratect 10%
10 ml
66.23
88.45
10 %
Infusion solution: Ex illo Immunoglobulinum Humanum Normale 96 %/ml
Biotest (Schweiz) AG
B / SL
FB
G
L
IP
V/S
Intratect 10%
50 ml
331.16
376.55
10 %
Infusion solution: Ex illo Immunoglobulinum Humanum Normale 96 %/ml
Biotest (Schweiz) AG
B / SL
FB
G
L
IP
V/S
Intratect 10%
100 ml
662.32
736.75
10 %
Infusion solution: Ex illo Immunoglobulinum Humanum Normale 96 %/ml
Biotest (Schweiz) AG
B / SL
FB
G
L
IP
V/S
Intratect 10%
200 ml
1324.63
1457.05
10 %
Infusion solution: Ex illo Immunoglobulinum Humanum Normale 96 %/ml
Biotest (Schweiz) AG
B / SL
FB
G
IP
CI
PP
Ryzodeg FlexTouch
5 x 3 ml
67.56
89.90
10 %
Injection solution: 3 Active Agents
Novo Nordisk Pharma AG
B / SL
FB
G
IP
CI
PP
Ryzodeg Penfill
5 x 3 ml
67.56
89.90
10 %
Injection solution: 3 Active Agents
Novo Nordisk Pharma AG
B / SL
FB
G
IP
Propofol MCT Fresenius 20
mg/ml Fertigspritze
syringe(s) à 50 ml
PR
PR
k.A.
Infusion emulsion: Propofolum 20 mg
Fresenius Kabi
(Schweiz) AG
B
FB
G
IP
Propofol MCT Fresenius 10
mg/ml Fertigspritze
syringe(s) à 50 ml
PR
PR
k.A.
Emulsion zur Injektion oder Infusion: Propofolum 10 mg
Fresenius Kabi
(Schweiz) AG
B
FB
G
IP
Propofol MCT Fresenius 10
mg/ml Fertigspritze
6 x 10 ml
PR
PR
k.A.
Emulsion zur Injektion oder Infusion: Propofolum 10 mg
Fresenius Kabi
(Schweiz) AG
B
FB
G
IP
Propofol MCT Fresenius 10
mg/ml Fertigspritze
6 x 20 ml
PR
PR
k.A.
Emulsion zur Injektion oder Infusion: Propofolum 10 mg
Fresenius Kabi
(Schweiz) AG
B
FB
G
IP
CI
Nicorette Mint
PR
PR
k.A.
Spray zur Anwendung in der Mundhöhle: Nicotinum 1 mg
JNTL Consumer Health II
(Switzerland) GmbH
D
FB
G
IP
Nicorette Fruit & Mint
PR
PR
k.A.
Spray zur Anwendung in der Mundhöhle: Nicotinum 1 mg
JNTL Consumer Health II
(Switzerland) GmbH
D
FB
G
IP
CI
Nicorette Mint
2
PR
PR
k.A.
Spray zur Anwendung in der Mundhöhle: Nicotinum 1 mg
JNTL Consumer Health II
(Switzerland) GmbH
D
FB
G
IP
Nicorette Fruit & Mint
2
PR
PR
k.A.
Spray zur Anwendung in der Mundhöhle: Nicotinum 1 mg
JNTL Consumer Health II
(Switzerland) GmbH
D
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
